Clinically significant interactions between drugs, microbiome, and sex

Key Points

• The research aims to investigate how microbiomes and sex differences affect drug metabolism and treatment outcomes.
• Conduct population pharmacokinetic studies with microbiome composition and sex as covariates.
• Perform clinical studies focusing on treatment outcomes related to microbiome interactions.
• Identified gaps in current understanding of microbiome effects on drug metabolism.
• Highlighted the lack of data on how sex influences these interactions.